Back to search
FDAFDA · Food and drugs·Recall number D-0435-2017

Donepezil Hydrochloride Tablets, 10 mg, packaged in a) 30-count bottles (NDC 0781-5275-31) and b) 1000-count bottles (NDC 0781-5275-10), Rx only, Manufactured in India by Sandoz Private Ltd for Sandoz Inc., Princeton, NJ 08540.

Published January 25, 2017 · Recall initiated: December 13, 2016

Summary

FDA records drug Class III recall D-0435-2017, published January 25, 2017 and initiated December 13, 2016. Recalling firm: Sandoz Inc; Status: Terminated; Reported quantity: a) 10,200 bottles; b) 300 bottles; Lot: Lot #: a) FJ6599, Exp 05/17 and b) FJ6600, Exp 05/17. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: out of specification results for assay test.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sandoz Inc
Distributor
Nationwide in the USA
Lot
Lot #: a) FJ6599, Exp 05/17 and b) FJ6600, Exp 05/17
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Donepezil Hydrochloride Tablets, 10 mg, packaged in a) 30-count bottles (NDC 0781-5275-31) and b) 1000-count bottles (NDC 0781-5275-10), Rx only, Manufactured in India by Sandoz Private Ltd for Sandoz Inc., Princeton, NJ 08540. recalled?

Yes. FDA published recall D-0435-2017 on January 25, 2017. Reported hazard: Subpotent Drug: out of specification results for assay test.

What should I do if I have this product?

Voluntary: Firm initiated · Letter